Recombinant Rhodopirellula baltica Ribosomal RNA small subunit methyltransferase H (rsmH)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Rhodopirellula baltica Ribosomal RNA Small Subunit Methyltransferase H (rsmH)

Recombinant Rhodopirellula baltica Ribosomal RNA small subunit methyltransferase H (rsmH) is an enzyme involved in the post-transcriptional modification of ribosomal RNA (rRNA). Specifically, it methylates the N4 position of cytidine at position 1402 (C1402) in the 16S rRNA, a crucial component of the bacterial ribosome's small subunit . This modification is essential for the proper functioning of the ribosome, particularly in the recognition and binding of transfer RNA (tRNA) during protein synthesis.

Mechanism of Action

rsmH is an AdoMet-dependent methyltransferase, meaning it uses S-adenosylmethionine (Ado-Met) as a methyl group donor to perform the methylation reaction . The enzyme specifically targets the assembled 30S ribosomal subunit but does not recognize naked 16S rRNA or tightly coupled 70S ribosomes as substrates . This specificity suggests that rsmH interacts with the 30S subunit during the late stages of ribosomal assembly.

Table: Key Features of rsmH

FeatureDescription
SubstrateAssembled 30S ribosomal subunit
ModificationN4-methylation of cytidine at position 1402 (C1402) in 16S rRNA
Methyl Group DonorS-adenosylmethionine (Ado-Met)
ConservationWidely conserved across bacterial species
FunctionEssential for ribosome function and translation initiation

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a guideline.
Shelf Life
Shelf life depends on several factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If a specific tag type is required, please inform us, and we will prioritize its development.
Synonyms
rsmH; mraW; RB8268; Ribosomal RNA small subunit methyltransferase H; EC 2.1.1.199; 16S rRNA m(4)C1402 methyltransferase; rRNA; cytosine-N(4)-)-methyltransferase RsmH
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-325
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Rhodopirellula baltica (strain DSM 10527 / NCIMB 13988 / SH1)
Target Names
rsmH
Target Protein Sequence
MTASQPLDQA DQDSESSSAG SSAAETEHVS VMPNEIVQWV REINPTTIID GTYGGGGHTR LLAEVLADAG SDSDTPRVIA IDRDPAVVRR DEQKSWIKDD PRIELFLGSY ESSPKALDAL DLTHADALVL DLGLSSDQLA DRNRGFTFTI DDAELDLRFD PENGVPAHRW LQQHSEKEIA DAIYRFGEER FSRRIAKQIF LRARERNPVT KVGELVEICR RCVPRSRNHD IHPATRTFQA LRIAVNDELG GLTRTLQSAP DWIAPGGRVA VISFHSLEDR IVKNAFREDH RWEILTKKPL RPTDEEVQAN PRSRSAKLRV AKRVE
Uniprot No.

Target Background

Function

This recombinant protein specifically methylates the N4 position of cytidine at position 1402 (C1402) within the 16S rRNA.

Database Links

KEGG: rba:RB8268

STRING: 243090.RB8268

Protein Families
Methyltransferase superfamily, RsmH family
Subcellular Location
Cytoplasm.

Q&A

How does rsmH differ from other methyltransferases in R. baltica?

While R. baltica possesses several methyltransferases involved in RNA modification, rsmH specifically targets the small ribosomal subunit. Unlike some other methyltransferases that may have broader substrate specificity, rsmH demonstrates high specificity for its target nucleotide in the 16S rRNA. Based on studies of similar enzymes in other bacteria, rsmH likely acts late in the assembly process and can modify completely assembled 30S subunits . This timing in the ribosome maturation pathway distinguishes it from other methyltransferases that may act earlier in the assembly process.

What experimental approaches are typically used to study recombinant R. baltica rsmH activity?

Researchers typically employ the following methods to study recombinant R. baltica rsmH:

  • Gene identification and cloning: BLAST searches using known rsmH sequences from related organisms to identify homologous genes in the R. baltica genome .

  • Recombinant expression systems: Expression in E. coli using vectors like pET systems, which has been successful for other R. baltica enzymes .

  • Protein purification: Affinity chromatography methods, often involving purification steps that yield proteins with specific activity measurements (e.g., μmol/min.mg) .

  • Activity assays: In vitro methylation assays using S-adenosyl-L-methionine as a methyl donor and isolated 16S rRNA or synthetic oligonucleotides containing the target sequence as substrates .

  • Verification in native systems: Comparison of recombinant enzyme activity with activity detected in R. baltica cell extracts to confirm functional characterization .

What is known about the crystal structure of bacterial rsmH proteins?

Based on studies of E. coli RsmH, which can serve as a model for understanding R. baltica RsmH, the crystal structure reveals several important features:

  • The enzyme consists of two distinct but structurally related domains: a typical methyltransferase (MTase) domain and a putative substrate recognition and binding domain .

  • A deep pocket exists in the conserved AdoMet binding domain, which accommodates the methyl donor substrate .

  • In crystal structures, the cytidine binding site is positioned approximately 25.9Å from AdoMet, indicating that the complex observed in crystals is not in a catalytically active state .

  • This spatial arrangement suggests that significant structural rearrangement of either the enzyme or the nucleotides neighboring the target C1402 is necessary to bring the substrates into proximity for catalysis .

These structural insights provide a framework for understanding how R. baltica RsmH likely functions and could inform strategies for recombinant protein engineering or inhibitor design.

How does oligomerization affect rsmH function?

Studies of E. coli RsmH indicate that while only one molecule exists in the asymmetric unit of crystals, the protein can form a compact dimer across a crystallographic twofold axis . Further analysis using small-angle X-ray scattering (SAXS) confirmed the presence of this dimer in solution, albeit with a more flexible conformation than observed in crystal structures . This flexibility likely results from the absence of substrate binding.

The dimeric architecture appears to be important for achieving the active status of RsmH in vivo . For recombinant R. baltica RsmH, researchers should consider how expression conditions and purification methods might affect oligomerization states and subsequent enzyme activity. Native gel electrophoresis or size exclusion chromatography could be employed to verify the oligomeric state of recombinant R. baltica RsmH preparations.

What expression systems work best for obtaining soluble recombinant rsmH from R. baltica?

Based on successful expression of other R. baltica enzymes and related methyltransferases, the following approaches are recommended:

  • Expression vector selection: pET expression systems have been successful for other R. baltica enzymes. When expressing R. baltica proteins, it's important to consider codon optimization, as has been necessary for other enzymes from this organism .

  • Host strain considerations: E. coli BL21(DE3) or derivatives are commonly used for methyltransferase expression .

  • Solubility enhancement: For methyltransferases that tend to form inclusion bodies (as observed with some related enzymes), fusion tags such as GST can improve solubility . Alternative approaches include:

    Solubility Enhancement StrategyApplicationExpected Outcome
    Reduced induction temperature16-20°C overnight inductionSlower protein folding, increased solubility
    Co-expression with chaperonesGroEL/GroES, DnaK systemsAssisted folding of recombinant protein
    Fusion tagsGST, MBP, SUMOEnhanced solubility, simplified purification
    Osmolyte supplementationSorbitol, glycine betaineStabilization of folding intermediates
  • Optimization of induction parameters: Low IPTG concentrations (0.1-0.5 mM) and lower growth temperatures have been effective for similar enzymes .

  • Purification strategy: For difficult-to-express proteins, preparatory SDS-PAGE with negative staining followed by electroelution has been employed as a last resort for related methyltransferases .

How can the methyltransferase activity of recombinant R. baltica rsmH be measured?

Several approaches can be used to measure rsmH activity:

  • Radiometric assays: Using 3H or 14C-labeled SAM as methyl donor and measuring incorporation of labeled methyl groups into rRNA substrate.

  • LC-MS/MS analysis: Detecting methylated nucleoside products after enzymatic digestion of the rRNA substrate.

  • Coupled enzyme assays: Monitoring SAH (S-adenosylhomocysteine) production as a byproduct of the methylation reaction using enzymes that convert SAH to measurable products.

  • Fluorescence-based assays: Using methyltransferase-coupled fluorescent assays that detect SAH production through coupled enzymatic reactions.

For accurate activity measurements, researchers should consider:

  • Using appropriate buffer conditions (typically containing magnesium)

  • Including controls for non-enzymatic methylation

  • Ensuring substrate accessibility if using intact 30S subunits

  • Verifying enzyme concentration and purity

What approaches can be used to identify the specific nucleotide targets of R. baltica rsmH?

To identify the specific nucleotide targets of R. baltica rsmH, researchers can employ the following techniques:

  • Comparative sequence analysis: Aligning R. baltica 16S rRNA with E. coli and other bacteria where the C1402 target is established to identify the equivalent position .

  • Primer extension analysis: After in vitro methylation, reverse transcriptase pauses or terminates at methylated positions, allowing identification of modification sites.

  • Mass spectrometry: Analyzing enzymatically digested 16S rRNA before and after treatment with recombinant rsmH to identify newly methylated nucleotides.

  • Mutational analysis: Creating point mutations in potential target sites of synthetic rRNA substrates to confirm specificity through loss of methylation activity.

  • Crystallography: Co-crystallizing rsmH with target RNA oligonucleotides to directly visualize the enzyme-substrate interaction .

These approaches can be used complementarily to establish with high confidence the exact nucleotide target of R. baltica rsmH within the 16S rRNA.

How does S-adenosyl-L-methionine (SAM) binding affect rsmH structure and function?

Based on structural studies of related methyltransferases, SAM binding induces conformational changes in rsmH that are essential for catalytic activity. In E. coli RsmH, a deep pocket within the conserved AdoMet binding domain accommodates the cofactor . The binding of SAM likely causes structural rearrangements that position the target cytidine residue correctly for methyl transfer.

The large distance (25.9Å) observed between bound cytidine and SAM in crystal structures suggests that significant conformational changes must occur to achieve a catalytically competent state . These changes may include:

  • Domain movements that bring the substrate and cofactor into proximity

  • Induced fit mechanisms upon substrate binding

  • Potential oligomerization effects that stabilize the active conformation

When working with recombinant R. baltica rsmH, researchers should consider including SAM in purification buffers or during activity assays to stabilize the enzyme's active conformation. Thermal shift assays (differential scanning fluorimetry) can be used to assess the stabilizing effect of SAM on the recombinant enzyme.

How can transcriptomic approaches be integrated with rsmH functional studies in R. baltica?

R. baltica has been successfully studied using whole genome microarray approaches to monitor gene expression throughout its growth curve . To integrate transcriptomic approaches with rsmH functional studies, researchers can:

  • Monitor rsmH expression across growth phases: Determine when rsmH is most highly expressed during the R. baltica life cycle using microarray or RNA-seq approaches .

  • Correlate with ribosome biogenesis genes: Analyze co-expression patterns between rsmH and other genes involved in ribosome assembly and maturation to identify functional relationships .

  • Stress response analysis: Examine how different environmental conditions (salt concentration, nutrient limitation, temperature) affect rsmH expression, which could provide insights into regulatory mechanisms .

  • Comparative expression analysis: Compare expression patterns with other methyltransferases to understand the coordination of various rRNA modifications during ribosome biogenesis .

  • Knockout/knockdown studies: Use transcriptomic profiling to assess global effects of rsmH depletion or deletion on gene expression patterns.

These approaches can reveal the regulatory networks governing rsmH expression and its integration with cellular physiology in R. baltica.

What are the potential biotechnological applications of recombinant R. baltica rsmH?

R. baltica possesses many biotechnologically promising features, including unique enzymes and metabolic capabilities . Based on the properties of rRNA methyltransferases, potential biotechnological applications for recombinant R. baltica rsmH include:

  • Ribosome engineering: Targeted methylation of heterologous rRNAs to potentially enhance translation fidelity or alter ribosome function in biotechnological applications.

  • Antibiotic development: As demonstrated with related methyltransferases in Wolbachia, specific inhibitors of rsmH could represent novel antimicrobial agents . The potential for selective inhibition makes such enzymes attractive drug targets.

  • RNA modification tools: Development of site-specific RNA methylation tools for synthetic biology applications, potentially enabling the creation of ribosomes with novel properties.

  • Structural biology platforms: Using the well-characterized structure of rsmH for the development of protein engineering platforms or for studying protein-RNA interactions.

  • Biomarkers: Utilizing the presence or activity of specific methyltransferases like rsmH as biomarkers for monitoring bacterial populations in environmental samples.

Research on these applications would benefit from improved expression systems for recombinant R. baltica rsmH that yield high amounts of active enzyme.

How might rsmH function differ in R. baltica compared to other bacteria given its unique cell biology?

Rhodopirellula baltica belongs to the Planctomycetes phylum, which exhibits unique cellular characteristics including an intriguing lifestyle and distinctive cell morphology . These unique features may influence rsmH function in several ways:

  • Compartmentalized cell structure: Planctomycetes possess membrane-bound cellular compartments that are unusual among bacteria. This compartmentalization might affect the localization and regulation of ribosome biogenesis, including rsmH activity .

  • Cell cycle regulation: R. baltica exhibits a complex life cycle with different cell morphologies. Transcriptomic studies suggest that numerous genes, including many hypothetical proteins, are differentially regulated during the cell cycle . RsmH activity might be coordinated with specific phases of this life cycle.

  • Adaptation to marine environment: As a marine organism, R. baltica has evolved mechanisms for salt resistance . These adaptations might extend to its ribosomes, potentially influencing the role of modifications catalyzed by rsmH.

  • Genomic plasticity: The reorganization of the genome during R. baltica's life cycle might affect the expression and regulation of rsmH, potentially linking ribosome biogenesis to cell cycle progression in unique ways.

Research comparing rsmH function between R. baltica and model organisms like E. coli could reveal novel aspects of ribosome biogenesis regulation in this biotechnologically promising phylum.

What are common challenges in expressing and purifying active recombinant R. baltica rsmH?

Based on experiences with related methyltransferases and other R. baltica enzymes, researchers may encounter these challenges:

  • Inclusion body formation: Methyltransferases often form insoluble aggregates when overexpressed in E. coli. This has been observed with related enzymes, which went completely into insoluble fractions despite multiple attempts at optimization .

  • Loss of activity during purification: As observed with other R. baltica enzymes, attempts to improve protein purity can sometimes lead to loss of activity . This suggests that certain contaminants or co-purifying factors might be important for stability or activity.

  • Protein stability issues: Methyltransferases may have stability requirements related to cofactor binding. Maintaining SAM in buffers might be necessary for protein stability.

  • Verification of correct start codon: In at least one case with R. baltica enzymes, the annotated start codon was incorrect, leading to expression of non-functional protein. Researchers identified a start codon 240 bp downstream that yielded active enzyme when expressed .

  • Oligomerization requirements: As observed with E. coli RsmH, the dimeric architecture may be essential for activity . Purification conditions that disrupt this oligomerization could yield inactive enzyme.

ChallengeRecommended SolutionReference
Inclusion body formationGST fusion tags, reduced temperature, co-expression with chaperones
Activity loss during purificationOptimize purification steps, test activity at each stage
Identifying correct start codonDesign multiple constructs with different potential start sites
Maintaining oligomeric stateInclude stabilizing additives, gentle purification methods
Low yield of active proteinCodon optimization, expression in cold-adapted E. coli strains

How can researchers verify that recombinant R. baltica rsmH has the correct folding and activity?

To verify proper folding and activity of recombinant R. baltica rsmH, researchers should employ multiple complementary approaches:

  • Comparative activity assays: Compare the activity of recombinant enzyme with activity detected in native R. baltica cell extracts, as has been done for other enzymes from this organism .

  • Structural characterization: Use circular dichroism (CD) spectroscopy to assess secondary structure content and thermal stability, comparing with known methyltransferase structural profiles.

  • Binding assays: Verify SAM binding through techniques like isothermal titration calorimetry (ITC) or differential scanning fluorimetry (DSF) to confirm the protein can properly bind its cofactor.

  • Size exclusion chromatography: Confirm the expected oligomeric state in solution, which is likely dimeric based on studies of related rsmH proteins .

  • Substrate specificity: Test methylation activity on both authentic 16S rRNA and control RNAs to confirm the enzyme exhibits the expected substrate specificity.

  • Mass spectrometry: Analyze the recombinant protein to confirm its intact mass and any post-translational modifications that might affect activity.

These validation steps are crucial before proceeding to detailed functional or structural studies with the recombinant enzyme.

What are the best approaches for studying the kinetics of recombinant R. baltica rsmH?

To accurately characterize the kinetic properties of recombinant R. baltica rsmH, researchers should consider:

  • Substrate preparation: Using either synthetic RNA oligonucleotides containing the target sequence or isolated 30S ribosomal subunits as substrates. Each approach has advantages:

    Substrate TypeAdvantagesLimitations
    Synthetic oligonucleotidesDefined sequence, ease of handlingMay lack tertiary structure context
    Isolated 30S subunitsPhysiologically relevantComplex preparation, heterogeneity
    In vitro transcribed 16S rRNAComplete sequence, controlled productionLacks other rRNA modifications
  • Optimized assay conditions: Determining optimal pH, salt concentration, and metal ion requirements before conducting kinetic studies.

  • Michaelis-Menten kinetics: Measuring initial velocities at varying substrate concentrations to determine Km and Vmax values for both SAM and RNA substrates.

  • Product inhibition studies: Assessing the effect of S-adenosylhomocysteine (SAH) accumulation on enzyme activity, which is often a limiting factor in methyltransferase reactions.

  • Temperature dependence: Characterizing the temperature optimum and stability, particularly relevant for a marine organism that may experience temperature fluctuations.

  • Multi-substrate kinetic analysis: Using methods such as product inhibition patterns or isotope exchange to determine the reaction mechanism (ordered, random, ping-pong).

  • Data analysis: Applying appropriate kinetic models that account for the bi-substrate nature of the methyltransfer reaction.

These approaches will provide comprehensive kinetic parameters to compare with other bacterial rsmH enzymes and understand any unique properties of the R. baltica enzyme.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.